THE ROLE OF PARICALCITOL ON PROTEINURIA

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease

2006 • 1,440 citations

1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells

2001 • 1,091 citations

Vitamin D

2005 • 1,077 citations

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

2004 • 956 citations

Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

2003 • 930 citations

Vitamin D levels and early mortality among incident hemodialysis patients

2007 • 783 citations

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation

1999 • 591 citations

Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence

2004 • 535 citations

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

2003 • 378 citations

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

2005 • 371 citations

Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease

2008 • 324 citations

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro

2007 • 289 citations

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase

2008 • 285 citations

Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy

2006 • 283 citations

The pleiotropic actions of vitamin D

2003 • 261 citations

Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1998 • 248 citations

Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor–Mediated Sequestration of NF-κB Signaling

2008 • 247 citations

1,25-Dihydroxyvitamin D ₃ Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice

1992 • 243 citations

1,25-Dihydroxyvitamin D₃decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

2004 • 221 citations

Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial

2009 • 188 citations

Vitamin D and Kidney Disease

2008 • 173 citations

A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis

2001 • 138 citations

Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats

2001 • 116 citations

1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression

2005 • 102 citations

Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial

2008 • 93 citations

Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells

2009 • 81 citations

Partial prevention of active Heymann nephritis by 1α, 25 dihydroxyvitamin D3

1993 • 75 citations

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease

2008 • 48 citations

The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics

2009 • 38 citations

Actions of 1,25-Dihydroxyvitamin D3 on Human Mesangial Cells

1991 • 30 citations

Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor

2009 • 26 citations

Cited By (0)

Loading...